Updated:
Kenvue
Kenvue supplies consumer-health products including Tylenol, Listerine and Neutrogena. Its Kimberly-Clark transaction remained pending in October 2026.
Overview
Kenvue supplies consumer-health products across Self Care, Skin Health and Beauty, and Essential Health. Its brands include Tylenol, BAND-AID Brand, Listerine, Neutrogena, Aveeno and Zyrtec. Its product portfolio serves everyday personal-care and health needs through retail and digital channels across international markets. Kimberly-Clark's proposed acquisition remained pending in its October 13, 2026 disclosure, which described debt-exchange amendments linked to an expected closing. For fiscal 2025, ended December 28, 2025, it reported USD 15,124,000,000 in revenue and net income of USD 1,470,000,000.
Company overview
- Legal name
- Kenvue Inc.
- Former names in filing history
- JNTL, Inc. (2022-08-30 to 2022-08-30)
- Classification
- Public company
- Industry (SIC)
- 2844 — Perfumes, Cosmetics & Other Toilet Preparations
- Headquarters
- Summit, NJ, United States
- Incorporated in
- DE
- SEC CIK
- 0001944048
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $15.1B | $1.5B | $27.1B | $1.1B | $2.2B | |
| FY2024USD | $15.5B | $1.0B | $25.6B | $1.1B | $1.8B | |
| FY2023USD | $15.4B | $1.7B | $27.9B | $1.4B | $3.2B |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | CURRENT REPORT | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | CURRENT REPORT | ||
| DEF 14A | DEF 14A | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | CURRENT REPORT | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Kenvue in Altss
Track this company’s investors, transactions and relationships in Altss.